Thromboviscometry as a tool for evaluation of thrombotic risk in systemic hypertension

Journal of Human Hypertension

Volumn 14, Issue 2, 2000, Pages 105-109

  Banerjee, R ^a   Puniyani, R R ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

Author keywords

Fibrinogen; Hypertension; Thrombus

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; FIBRINOGEN; THROMBIN;

ADULT; ARTICLE; BLOOD VISCOSITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEMATOCRIT; HUMAN; HYPERTENSION; RISK ASSESSMENT; THROMBOGENESIS; THROMBOVISCOMETRY; THROMBUS; VISCOMETRY;

EID: 0033961180     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000946     Document Type: Article

References (10)

1. Ding YA. Thrombogenic and lipid risk factors in hypertension and coronary artery disease. Jpn Circ J 1996; 60: 75-84.
2. Lip GY et al. Relation of endothelium, thrombogenesis, and haemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. Am J Cardiol 1997; 80: 1566-1571.
3. Koenig W, Ernst E. The possible role of haemorheology in atherothrombogenesis. Atherosclerosis 1992; 94: 93-107.
4. Lip GY, Li-Saw-Hee FL. Does hypertension confer a hypercoagulable state? J Hypertens 1998; 16: 913-916.
5. Hartet H, Schaeder JA. The physical and biological constants of thromboelastography. Biorheology 1962; 1: 31-40.
6. Liao F, Li W, Huang S. Hemorheological investigation of clotting by rotational viscometer. Clin Hemorheol 1987; 7: 671-677.
7. Montalescot G, Collet JP, Choussat R, Thomas D. Fibrinogen as a risk factor for coronary heart disease. Eur Heart J 1998; 19: H11-H17.
8. Beumer N et al. Fibrinogen and the albumin-globulin ratio in recurrent stroke. Stroke 1993; 24: 1133-1139.
9. Puniyani RR, Sonar S. Haemorheological changes at menopause. Clin Hemorheol 1991; 11: 397-403.
10. Imperatore G et al. Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study. Diabetes Care 1998; 21: 649-654.